Reference centiles for the gross motor function measure and identification of therapeutic effects in children with cerebral palsy.
Cerebral Palsy
/ diagnosis
Child
Child Development
Child, Preschool
Disability Evaluation
Disease Progression
Female
Germany
Humans
Male
Monitoring, Physiologic
/ methods
Motor Skills
Outcome Assessment, Health Care
/ methods
Physical Therapy Modalities
Retrospective Studies
Severity of Illness Index
cerebral palsy
effect size
gross motor function
therapy effect
Journal
Journal of evaluation in clinical practice
ISSN: 1365-2753
Titre abrégé: J Eval Clin Pract
Pays: England
ID NLM: 9609066
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
06
02
2018
revised:
19
06
2018
accepted:
20
06
2018
pubmed:
22
7
2018
medline:
27
4
2019
entrez:
21
7
2018
Statut:
ppublish
Résumé
Children with cerebral palsy (CP) can show an increase in gross motor function until the age of 9 to 10 years under the standard of care. Additionally, the motor development can have large individual fluctuations. Therefore, in clinical setting, it is not trivial to estimate the effect of an additional therapeutic intervention at this age interval. The study aim was to develop a method which allows quantification of the gross motor function changes over 6 months of the individual child with CP. The present study was a single center retrospective analysis. Data were collected in children with CP who participated in a rehabilitation program between 2006 and 2016. The gross motor function of the children was measured with the Gross Motor Function Measurement (GMFM-66). Reference centiles for the GMFM-66 were created with data before starting the rehabilitation program. The variability of the evolution of the GMFM-66 was assessed with data at the start and the end of a 6-month observational phase of standard of care. In total, the GMFM-66 data of 919 children before starting the rehabilitation program were available (age 6.49 ± 2.49 years, GMFCS-level I-V). For 515 study participants (6.76 ± 2.30 years, GMFCS-level I-V), data were also available at the start and the end of a 6-month observational phase. The presented method helps to guide the clinician to track the individual patient's gross motor development and assess the additional effect of an additionally applied intervention while taking into account the expected progression of gross motor function under standard of care.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
78-87Informations de copyright
© 2018 John Wiley & Sons, Ltd.